FK506 Binding Protein 4, 59kDa (FKBP4) Peptid
FKBP4
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN936787
382,12 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 27 Werktagen
Kurzübersicht für FK506 Binding Protein 4, 59kDa (FKBP4) Peptid (ABIN936787)
Target
FKBP4
(FK506 Binding Protein 4, 59kDa (FKBP4))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- ANMFERLAEE ENKAKAEASS GDHPTDTEMK EEQKSNTAGS QSQVETEA
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of FKBP4 antibody,
Alternative Names: FKBP4 control peptide, FKBP4 antibody Blocking Peptide, Anti-FKBP4 Blocking Peptide, FK506 binding protein 4, 59kDa Blocking Peptide, FKBP52 Blocking Peptide, FKBP59 Blocking Peptide, HBI Blocking Peptide, Hsp56 Blocking Peptide, PPIase Blocking Peptide, p52 Blocking Peptide, FKBP4, FKBP-4, FKBP 4, FKBP-4 Blocking Peptide, FKBP 4 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- FKBP4 (FK506 Binding Protein 4, 59kDa (FKBP4))
-
Hintergrund
- This encoded protein is known to associate with phytanoyl-CoA alpha-hydroxylase. It can also associate with two heat shock proteins (hsp90 and hsp70) and thus may play a role in the intracellular trafficking of hetero-oligomeric forms of the steroid hormone receptors. This protein correlates strongly with adeno-associated virus type 2 vectors (AAV) resulting in a significant increase in AAV-mediated transgene expression in human cell lines. Thus this encoded protein is thought to have important implications for the optimal use of AAV vectors in human gene therapy.
-
Molekulargewicht
- 52 kDa
Target
-
Sie sind hier:
